Viral kinetic modeling and simulation of the impact of non-pharmaceutical COVID-19 interventions in different countries: model-informed respiratory disease trial design
I. Faddeenkov (Lyon, France), S. Arsène (Lyon, France), C. Couty (Lyon, France), N. Go (Lyon, France), S. Granjeon-Noriot (Lyon, France), D. Šmit (Lyon, France), R. Kahoul (Lyon, France), B. Illigens (Lyon, France), J. Boissel (Lyon, France), A. Chevalier (Meyrin, Switzerland), L. Lehr (Meyrin, Switzerland), C. Pasquali (Meyrin, Switzerland), A. Kulesza (Lyon, France)
Source: International Congress 2022 – COVID basic science
Session: COVID basic science
Session type: Thematic Poster
Number: 4080
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Faddeenkov (Lyon, France), S. Arsène (Lyon, France), C. Couty (Lyon, France), N. Go (Lyon, France), S. Granjeon-Noriot (Lyon, France), D. Šmit (Lyon, France), R. Kahoul (Lyon, France), B. Illigens (Lyon, France), J. Boissel (Lyon, France), A. Chevalier (Meyrin, Switzerland), L. Lehr (Meyrin, Switzerland), C. Pasquali (Meyrin, Switzerland), A. Kulesza (Lyon, France). Viral kinetic modeling and simulation of the impact of non-pharmaceutical COVID-19 interventions in different countries: model-informed respiratory disease trial design. 4080
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|